[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339433-105":59,"doc-detail-339433-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","salivary-gland-type-cancers-cross-organ-demographics-of-a-rare-cancer","Salivary gland-type cancers: cross-organ demographics of a rare cancer","","Cross-organ demographics of salivary gland-type cancers (SGTCs) address the rarity and histologic diversity of tumors that can arise beyond major salivary glands. A retrospective cohort analyzed 2009–2019 cases from salivary duct carcinoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, epithelial-myoepithelial carcinoma, acinic cell carcinoma, and polymorphous adenocarcinoma, classifying primary sites across major salivary glands, head/neck, broncho-pulmonary regions, and others. Among 173 patients, site distributions and survival differences, particularly improved overall survival in mucoepidermoid carcinoma, were evaluated to support clinical significance and unmet therapeutic needs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/salivary-gland-type-cancers-cross-organ-demographics-of-a-rare-cancer/339433/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/salivary-gland-type-cancers-cross-organ-demographics-of-a-rare-cancer/339433.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are salivary gland-type cancers (SGTCs) and why is cross-organ study important?","Question",{"text":112,"@type":113},"SGTCs are histologically heterogeneous cancers that can affect organs beyond the salivary glands. Comprehensive cross-organ studies are described as limited, motivating the present investigation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the primary tumor sites classified in the study?",{"text":117,"@type":113},"Primary sites were grouped into four categories: major salivary glands, head/neck excluding major salivary glands regions, broncho-pulmonary regions, and others. The head/neck excluding major salivary glands was further divided into nasal/paranasal sinus, oral, and pharynx/larynx.",{"name":119,"@type":110,"acceptedAnswer":120},"What survival finding differentiated mucoepidermoid carcinoma from other subtypes?",{"text":121,"@type":113},"The overall survival time of patients with mucoepidermoid carcinoma was significantly better than that of patients with salivary duct carcinoma or epithelial-myoepithelial carcinoma.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339433,1790870312,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","International Journal of Clinical Oncology (2024) 29:755–763  \n[https://doi.org/10.1007/s10147-024-02505-3](https://doi.org/10.1007/s10147-024-02505-3)  \nSalivary gland‑type cancers: cross‑organ demographics of a rare cancer  \nAikaTanzawa1,2 · Kengo Saito3 · Masayuki Ota4 · Koji Takahashi1 · Izumi Ohno1 · Toyoyuki Hanazawa5 · Katsuhiro Uzawa2 · Yuichi Takiguchi1  \nReceived: 29 November 2023 / Accepted: 6 March 2024 / Published online: 16 March 2024 © The Author(s) 2024  \nAbstract  \nBackground Salivary gland-type cancers (SGTCs) are histologically heterogeneous and can affect organs other than the salivary glands. Some tumors outside the salivary glands are diagnosed on their unique histological characteristics. Comprehensive cross-organ studies on SGTCs are limited.  \nMethods We retrospectively analyzed the data of patients with salivary duct carcinoma (SDC), adenoid cystic carcinoma (AdCC), mucoepidermoid carcinoma (MEC), epithelial-myoepithelial carcinoma (EMC), acinic cell carcinoma (AcCC), and polymorphous adenocarcinoma (PAC) who visited our institution between 2009 and 2019. The primary tumor sites were classified into four categories; major salivary glands, head/neck (H/N) excluding (exc) major salivary glands (MSG) regions, broncho-pulmonary regions, and “others”. H/N exc MSG was further divided into three subcategories, nasal/paranasal sinus, oral and pharynx/larynx.  \nResults We identified 173 patients with SGTCs, with SDC, AdCC, MEC, EMC, AcCC, and PAC accounting for 20%, 42%, 27%, 3%, 8%, and 1% of the cases, respectively. The most frequent primary site was the major salivary glands (64%), followed by H/N exc MSG regions (27%), broncho-pulmonary regions, and “others”, thus non-salivary gland origins accounted for 9% of all cases. Patients with SDC, MEC, AcCC, or SGTC of the major salivary glands and broncho-pulmonary regions were more frequently treated by surgery. The overall survival time of the patients with MEC was significantly better than that of patients with SDC or EMC.  \nConclusions This cross-organ study highlights the clinical significance of SGTCs, underscoring the need for developing novel therapies for this rare disease entity.  \nKeywords Cross-organ · Broncho-pulmonary · Adenoid cystic carcinoma · Mucoepidermoid carcinoma · Epithelialmyoepithelial carcinoma · Acinic cell carcinoma  \n* Yuichi Takiguchi[takiguchi@faculty.chiba-u.jp](takiguchi@faculty.chiba-u.jp)  \n1 Department of Medical Oncology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan  \n2 Department of Oral Science, Graduate School of Medicine, Chiba University, Chiba, Japan  \n3 Department of Molecular Virology, Graduate School of Medicine, Chiba University, Chiba, Japan  \n4 Department of Diagnostic Pathology, Graduate School of Medicine, Chiba University, Chiba, Japan  \n5 Department of Otorhinolaryngology/Head and Neck Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan  \nIntroduction  \nSalivary gland tumors are rare, occurring at an incidence of 2.5 to 3.0 cases per 100,000 people per year in the Western world [1] . As of 2021, malignant salivary gland tumors accounted for only 0.2% of all cancers registered by the “Designated Cancer Care Hospitals” in Japan [2] . However, these tumors are heterogeneous, comprising almost 40 histological types [3] . Among these, carcinomas account for approximately 20% of all tumors of the parotid gland, 50% of all tumors of the submandibular glands, and 80% of all tumors of the minor salivary glands [4 , 5] . Malignant tumors of the salivary glands include salivary duct carcinoma (SDC), adenoid cystic carcinoma (AdCC), mucoepidermoid carcinoma (MEC),  \nepithelial-myoepithelial carcinoma (EMC), acinic cell carcinoma (AcCC), polymorphous adenocarcinoma (PAC), and others [6] .  \nA majority of the aforementioned tumors are considered to originate from the three major salivary glands: the parotid, the submandibular, and the sublingual glands. Howeve","cbCaivRJWg2KhC0a","https://ap.wps.com/l/cbCaivRJWg2KhC0a","pdf",614617,"English","# Abstract\n# Introduction\n## Background and rationale\n## Epidemiology and treatment landscape","[{\"question\":\"What are salivary gland-type cancers (SGTCs) and why is cross-organ study important?\",\"answer\":\"SGTCs are histologically heterogeneous cancers that can affect organs beyond the salivary glands. Comprehensive cross-organ studies are described as limited, motivating the present investigation.\"},{\"question\":\"How were the primary tumor sites classified in the study?\",\"answer\":\"Primary sites were grouped into four categories: major salivary glands, head/neck excluding major salivary glands regions, broncho-pulmonary regions, and others. The head/neck excluding major salivary glands was further divided into nasal/paranasal sinus, oral, and pharynx/larynx.\"},{\"question\":\"What survival finding differentiated mucoepidermoid carcinoma from other subtypes?\",\"answer\":\"The overall survival time of patients with mucoepidermoid carcinoma was significantly better than that of patients with salivary duct carcinoma or epithelial-myoepithelial carcinoma.\"}]","Salivary gland-type cancers: cross-organ demographics of a rare cancer | PDF",1790030272,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a55a1e2132f4cf9e44a6f172609d5d9d.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ed3d255e52e6704803ec04b30315b2c.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/848d5311538f4d42710f3f4d232a3d51.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e053051912b74fc47c1e509c4555150d.webp",980,1301]